Ruth Lofton, FNP-C | |
979 N Gilbert Rd Ste 102, Gilbert, AZ 85234-3307 | |
(480) 486-3913 | |
Not Available |
Full Name | Ruth Lofton |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 979 N Gilbert Rd Ste 102, Gilbert, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205458205 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 240091 (Arizona) | Secondary |
363LF0000X | Nurse Practitioner - Family | 240091 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ruth Lofton, FNP-C 3477 W Silverdale Rd, San Tan Valley, AZ 85144-2542 Ph: (480) 486-3913 | Ruth Lofton, FNP-C 979 N Gilbert Rd Ste 102, Gilbert, AZ 85234-3307 Ph: (480) 486-3913 |
News Archive
Doctors evaluating patients for blockages in the heart are aided by having a good roadmap of the vascular terrain before they can insert stents to clear the impasse.
From Thanksgiving to New Year's, there are many wishes for everyone to have a blissful and celebratory holiday season. But for many people, the holidays bring more misery than mirth, particularly at a time when the ailing economy can't seem to recover quickly enough and money worries remain on people's minds.
A simple new tool that tracks cognitive performance in adults aims to help physicians identify people who may be on the path to Alzheimer disease or another form of dementia. The tool, called the QuoCo (cognitive quotient), is published in CMAJ.
Pharmexa presents data from the HER-2 Protein AutoVacâ„¢ breast cancer trial at a Conference in Hamburg Summary: Pharmexa is presenting data from the first clinical trial in USA with the HER-2 Protein AutoVacâ„¢ vaccine at the 4th European Breast Cancer Conference (EBCC) in Hamburg, Germany.
A new report, titled "Injection Drug Use in Ukraine" and published by the Center for Strategic & International Studies (CSIS), examines the challenges of providing HIV prevention and care services in the country, particularly to people who inject drugs (PWID), who accounted for "nearly 50 percent of new HIV infections registered in 2010," according to the CSIS website.
› Verified 4 days ago